CRISPR THERAPEUTICS, INC. for CRISPR THERAPEUTICS, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Value-based payment models; new payment models; CMS national coverage determinations; drug approval pathways under FDA User Fee programs; drug development incentives
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Vice President, Government Affairs |
Medicare/Medicaid MMM
Value-based payment models; new payment models; CMS national coverage determinations; drug approval pathways under FDA User Fee programs; drug development incentives
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Vice President, Government Affairs |
Pharmacy PHA
Value-based payment models; new payment models; CMS national coverage determinations; drug approval pathways under FDA User Fee programs; drug development incentives
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Vice President, Government Affairs |
Medical/Disease Research/Clinical Labs MED
Value-based payment models; new payment models; CMS national coverage determinations; drug approval pathways under FDA User Fee programs; drug development incentives
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Vice President, Government Affairs |
Science/Technology SCI
Value-based payment models; new payment models; CMS national coverage determinations; drug approval pathways under FDA User Fee programs; drug development incentives
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MARTIN New | Vice President, Government Affairs |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | Switzerland | Switzerland | 100.0% | $100,000 |
Affiliated organisations
| Organisation | Location |
|---|---|
| CRISPR THERAPEUTICS AG | Zug, CH |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.